Jonathan Abramowitz | |
|---|---|
Abramowitz in 2026 | |
| Born | Jonathan Stuart Abramowitz June 11, 1969 |
| Education | |
| Occupations | Clinical psychologist, professor, researcher, author |
| Organization | University of North Carolina at Chapel Hill |
| Known for | Research on OCD; exposure and response prevention; OCD assessment |
| Website | |
Jonathan Stuart Abramowitz (born June 11, 1969) is an American clinical psychologist, researcher, and professor of psychology at the University of North Carolina at Chapel Hill (UNC-CH). His research focuses on obsessive–compulsive disorder (OCD) and anxiety disorders.
Abramowitz served as president of the Association for Behavioral and Cognitive Therapies (ABCT) in 2015 and was the founding editor-in-chief of the Journal of Obsessive-Compulsive and Related Disorders. He directs the Clinical Psychology PhD Training Program at the University of North Carolina at Chapel Hill.
Abramowitz earned a B.A. in Psychology from Muhlenberg College in 1991, an M.A. in psychology from Bucknell University in 1993, and a Ph.D. in clinical psychology from the University of Memphis in 1998. He completed his predoctoral internship and postdoctoral fellowship at the Center for Treatment and Study of Anxiety at the University of Pennsylvania.
From 2000-2006 he held clinical and academic appointments at the Mayo Clinic (Rochester, Minnesota). In 2006 he joined the faculty of the University of North Carolina at Chapel Hill, where he is a professor in the Department of Psychology and Neuroscience.
Abramowitz has published books, book chapters, and peer reviewed journal articles on OCD and anxiety disorders. He has served on editorial boards of several scientific journals and is a member of the International OCD Foundation's Scientific and Clinical Advisory Board.
Abramowitz studies psychological treatments for OCD, particularly exposure and response prevention (ERP). His work includes treatment studies, reviews, and meta-analyses, and investigations of factors associated with treatment response. He and his colleagues have also examined the integration of cognitive and acceptance-based strategies, including acceptance and commitment therapy (ACT) into OCD treatment.
Abramowitz has also written about the application of extinction and inhibitory learning to exposure-based treatment of OCD.
Abramowitz has studied the classification of OCD symptoms into dimensions, including contamination, responsibility for harm, unwelcome thoughts, and symmetry or incompleteness concerns.
In 2010, Abramowitz and colleagues developed the Dimensional Obsessive-Compulsive Scale (DOCS), a 20-item self-report instrument designed to assess the severity of four major OCD symptom dimensions. He has also collaborated on the development and evaluation of brief OCD screening instruments, including the four-item Obsessive-Compulsive Inventory (OCI-4).
Abramowitz has investigated cognitive and behavioral processes associated with OCD, including factors involved in the development and maintenance of symptoms. More recently, he and his colleagues have proposed a framework for understanding OCD symptoms in terms of underlying affective and motivational processes, including avoidance of perceived threat, guilt, disgust, and feelings of incompleteness, rather than primarily by symptom content.
Abramowitz has studied scrupulosity, form of OCD involving religious or moral obsessions and compulsions. He co-developed the Penn Inventory of Scrupulosity (PIOS), a self-report measure of religious obsessions and compulsions. He has also published a cognitive-behavioral analysis of scrupulosity examining its relationship to religious practices and implications for exposure and response prevention.
Abramowitz has studied obsessive-compulsive symptoms during pregnancy and the postpartum period, including the intrusive thoughts, cognitive risk factors, and predictors of postpartum OCD symptoms. He also collaborated on the development and evaluation of Baby PREP, a prevention program to reduce postpartum OCD symptoms. More recent studies have examined relationships among perinatal OCD symptoms, depression, partner relationship quality, and maternal-infant bonding.
Abramowitz has also worked on research examining cultural and religious influences on OCD symptoms and their assessment.
Abramowitz served as president of the Association for Behavioral and Cognitive Therapies (ABCT) from 2014 to 2015 and is a Fellow of the association. He has also served on the Board of Directors of the Anxiety and Depression Association of America and is a member of the Scientific and Clinical Advisory Board of the International OCD Foundation.
Abramowitz was the founding editor-in-chief of the Journal of Obsessive-Compulsive and Related Disorders.
Abramowitz received Muhlenberg College's Alumni Achievement Award (2011) and the UNC-Chapel Hill Faculty Award for Excellence in Doctoral Mentoring (2020).
{{cite journal}}: CS1 maint: article number as page number (link){{cite journal}}: CS1 maint: article number as page number (link)